Radiofrequency ablation for supraventricular tachycardia

P. A. Heidenreich, C. H.F. Cheng, G. D. Sanders, M. A. Hlatky, K. M. McDonald, B. K. Lee, M. S. Larson, D. K. Owens

Research output: Contribution to journalReview articlepeer-review


We compared radiofrequency ablation with drug treatment for patients with symptomatic supraventricular reentrant tachycardia using a cost-effectiveness model. For patients with monthly episodes of arrhythmia, ablation was more effective and less expensive than drug therapy. For patients with less frequent episodes, ablation was associated with better outcomes, at a cost well within that of other commonly accepted health interventions. Radiofrequency ablation remained more effective and less expensive than drug therapy even after varying our estimates of efficacy, complications, and costs.

Original languageEnglish (US)
Pages (from-to)8-12
Number of pages5
JournalCardiology Review
Issue number11
StatePublished - Jan 1 2001
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Radiofrequency ablation for supraventricular tachycardia'. Together they form a unique fingerprint.

Cite this